Abstract
Purpose
The imaging discrimination between neurofibroma (NF) and malignant peripheral nerve sheath tumor (MPNST) is clinically very important. The purpose of this study is to define the criteria for the differential diagnosis between NF and MPNST on MRI in neurofibromatosis 1 (NF1).
Methods
A total of 37 patients with NF1, 18 NFs and 19 MPNSTs were evaluated by MRI at 1.5 T. Magnetic resonance imaging (MRI) findings were compared using univariate and multivariate analyses.
Results
The MRI findings characteristic of MPNST (p < 0.05) were an irregular tumor shape (15/19 in MPNST vs. 5/18 in NF), unclear margin (13/19 in MPNST vs. 6/18 in NF), intra-tumoral lobulation (12/19 in MPNST vs. 3/18 in NF), presence of high signal-intensity area on T1-weighted images (T1WI) (12/19 in MPNST vs. 1/18 in NF), no target sign (0/19 in MPNST vs. 12/18 in NF), inhomogeneous enhancement on contract-enhanced T1WI (17/18 in MPNST vs. 9/16 in NF) and a lower rate of enhanced area (54% in MPNST vs. 87% in NF) were critical indicators to differentiate MPNST from NF. A multivariate analysis showed that intra-tumoral lobulation and the presence of a high signal-intensity area on T1WI were considered to be diagnostic indicators of MPNST. The sensitivity and specificity for these two items were 63.2, 83.3, 63.2 and 87.5%, respectively.
Conclusion
MRI shows features which were helpful for differentiating MPNST from NF.
Similar content being viewed by others
References
Bass JC, Korobkin M, Francis IR, Ellis JH, Cohan RH (1994) Retroperitoneal plexiform neurofibromas: CT findings. AJR Am J Roentgenol 163:617–620
Benedikt RA, Jelinek JS, Kransdorf MJ, Moser RP, Berrey BH (1994) MR imaging of soft-tissue masses: role of gadopentetate dimeglumine. J Magn Reson Imaging 4:485–490. doi:10.1002/jmri.1880040341
Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD (1997) MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 27:124–129. doi:10.1007/s002470050082
Cardona S, Schwarzbach M, Hinz U, Dimitrakopoulou-Strauss A, Attigah N, Mechtersheimer section sign G, Lehnert T (2003) Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours. Eur J Surg Oncol 29:536–541. doi:10.1016/S0748-7983(03)00055-6
Coleman BG, Arger PH, Dalinka MK, Obringer AC, Raney BR, Meadows AT (1983) CT of sarcomatous degeneration in neurofibromatosis. AJR Am J Roentgenol 140:383–387
Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ (1992) Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 185:581–586
Ferner RE, Lucas JD, O’Doherty MJ, Hughes RA, Smith MA, Cronin BF, Bingham J (2000) Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 68:353–357. doi:10.1136/jnnp.68.3.353
Fortman BJ, Kuszyk BS, Urban BA, Fishman EK (2001) Neurofibromatosis type 1: a diagnostic mimicker at CT. Radiographics 21:601–612
Hughes TM, Spillane AJ (2000) Imaging of soft tissue tumours. Br J Surg 87:259–260. doi:10.1046/j.1365-2168.2000.01412.x
Jee WH, Oh SN, McCauley T, Ryu KN, Suh JS, Lee JH, Park JM, Chun KA, Sung MS, Kim K, Lee YS, Kang YK, Ok IY, Kim JM (2004) Extraaxial neurofibromas versus neurilemmomas: discrimination with MRI. AJR Am J Roentgenol 183:629–633
King AA, DeBaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93:388–392. doi:10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#
Korf BR (1999) Plexiform neurofibromas. Am J Med Genet 89:31–37. doi:10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W
Kransdorf MJ, Jelinek JS, Moser RP Jr, Utz JA, Brower AC, Hudson TM, Berrey BH (1989) Soft-tissue masses: diagnosis using MR imaging. AJR Am J Roentgenol 153:541–547
Kumar AJ, Kuhajda FP, Martinez CR, Fishman EK, Jezic DV, Siegelman SS (1983) Computed tomography of extracranial nerve sheath tumors with pathological correlation. J Comput Assist Tomogr 7:857–865
Lawrence W Jr, Donegan WL, Natarajan N, Mettlin C, Beart R, Winchester D (1987) Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg Apr 205:349–359
Lee J, Sohn SK, Ahn BC, Chun KA, Lee K, Kim CK (1997) Sarcomatous transformation of neurofibromas. Comparative imaging with Ga-67, Tl-201, Tc-99 m pentavalent DMSA and Tc-99 m MIBI. Clin Nucl Med 22:610–614. doi:10.1097/00003072-199709000-00006
Levine E, Huntrakoon M, Wetzel LH (1987) Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. AJR Am J Roentgenol 149:1059–1064
Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knöfel MT, Wenzel R, Fünsterer C (2003) Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 45:618–625. doi:10.1007/s00234-003-0964-6
McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, Kingston H, Super M, Harris R, Evans DG (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36:197–203
Anonymous (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578
Otsuka H, Graham MM, Kubo A, Nishitani H (2005) FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report. Ann Nucl Med 19:55–58
Ramanathan RC, Thomas JM (1999) Malignant peripheral nerve sheath tumours associated with von Recklinghausen’s neurofibromatosis. Eur J Surg Oncol 25:190–193. doi:10.1053/ejso.1998.0625
Sakai F, Sone S, Kiyono K, Maruyama A, Ueda H, Aoki J, Kawai T, Ishii K, Morimoto M, Haniuda M et al (1992) Intrathoracic neurogenic tumors: MR-pathologic correlation. AJR Am J Roentgenol 159:279–283
Solomon SB, Semih Dogan A, Nicol TL, Campbell JN, Pomper MG (2001) Positron emission tomography in the detection and management of sarcomatous transformation in neurofibromatosis. Clin Nucl Med 26:525–528. doi:10.1097/00003072-200106000-00009
van der Woude HJ, Verstraete KL, Hogendoorn PC, Taminiau AH, Hermans J, Bloem JL (1998) Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? Radiology 208:821–828
Vanhoenacker FM, De Schepper AM, Gielen JL, Parizel PM (2005) MR imaging in the diagnosis and management of inheritable musculoskeletal disorders. Clin Radiol 60:160–170. doi:10.1016/j.crad.2004.06.003
Weisss SW, Goldbulum JR (2008) Malignant tumors of the perioheral nerves. In: Weisss SW, Goldbulum JR (eds) Enzinger and Weiss’s soft tissue tumors, 5th edn. Elsevier, Netherlands, pp 903–944
Acknowledgments
We thank the secretarial staff (Chie Usui, Chiyuki Ueno and Mariko Tanaka) of the Department of Orthopedic Surgery, Mie University Graduate School of Medicine, for their generous cooperation. This work is supported in part by the grant from the Ministry of Health, Labour and Welfare (Grants-in Aid for Clinical Cancer Research).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsumine, A., Kusuzaki, K., Nakamura, T. et al. Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI. J Cancer Res Clin Oncol 135, 891–900 (2009). https://doi.org/10.1007/s00432-008-0523-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-008-0523-y